Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01.06.15 |
Founder | 60 | 08.12.03 | |
President | 57 | 02.03.23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13.04.21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19.12.22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02.03.23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02.03.23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04.11.19 |
Muffy Carter
LAW | General Counsel | 71 | 29.11.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 55 | 02.03.23 | |
Director/Board Member | 62 | 02.03.23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01.06.15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Unternehmenskontakt
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+9.42% | 114 Mrd. | |
+11.84% | 104 Mrd. | |
-14.15% | 22.41 Mrd. | |
-1.05% | 22.28 Mrd. | |
-5.29% | 19.07 Mrd. | |
-38.29% | 18 Mrd. | |
-4.16% | 17.89 Mrd. | |
+7.99% | 14.28 Mrd. | |
+36.24% | 12.55 Mrd. |